- Home
- MNKD vs CENX Comparison
MNKD vs CENX Comparison
Compare MNKD & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- CENX
- Stock Information
- Founded
- MNKD 1991
- CENX 1995
- Country
- MNKD United States
- CENX United States
- Employees
- MNKD N/A
- CENX N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- CENX Aluminum
- Sector
- MNKD Health Care
- CENX Industrials
- Exchange
- MNKD Nasdaq
- CENX Nasdaq
- Market Cap
- MNKD 1.6B
- CENX 1.9B
- IPO Year
- MNKD 2004
- CENX 1996
- Fundamental
- Price
- MNKD $4.98
- CENX $18.40
- Analyst Decision
- MNKD Buy
- CENX Strong Buy
- Analyst Count
- MNKD 6
- CENX 3
- Target Price
- MNKD $8.92
- CENX $23.00
- AVG Volume (30 Days)
- MNKD 2.0M
- CENX 1.7M
- Earning Date
- MNKD 05-07-2025
- CENX 04-30-2025
- Dividend Yield
- MNKD N/A
- CENX N/A
- EPS Growth
- MNKD N/A
- CENX N/A
- EPS
- MNKD 0.10
- CENX 3.27
- Revenue
- MNKD $285,504,000.00
- CENX $2,220,300,000.00
- Revenue This Year
- MNKD $14.66
- CENX $7.73
- Revenue Next Year
- MNKD $14.27
- CENX $7.23
- P/E Ratio
- MNKD $49.50
- CENX $5.55
- Revenue Growth
- MNKD 43.50
- CENX 1.60
- 52 Week Low
- MNKD $3.97
- CENX $11.40
- 52 Week High
- MNKD $7.63
- CENX $25.39
- Technical
- Relative Strength Index (RSI)
- MNKD 36.48
- CENX 45.28
- Support Level
- MNKD $4.89
- CENX $17.27
- Resistance Level
- MNKD $5.12
- CENX $19.59
- Average True Range (ATR)
- MNKD 0.13
- CENX 0.95
- MACD
- MNKD 0.00
- CENX -0.09
- Stochastic Oscillator
- MNKD 21.82
- CENX 31.65
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.